Conjugate pneumococcal vaccines: Need and choice in India
Authors:
Open Access
- 1 January 2013
- journal article
- editorial
- Published by Medknow in Indian Journal of Community Medicine
- Vol. 38 (4) , 189-91
Abstract
Indian Journal of Community Medicine, the official organ of the Indian Association of Preventive and Social Medicine (IAPSM), IndiaKeywords
This publication has 11 references indexed in Scilit:
- Immunogenicity and Safety of a 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers Given With Routine Vaccines in IndiaThe Pediatric Infectious Disease Journal, 2013
- Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trialThe Lancet, 2013
- Changing Trends in Antimicrobial Resistance and Serotypes of Streptococcus pneumoniae Isolates in Asian Countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) StudyAntimicrobial Agents and Chemotherapy, 2012
- Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccineVaccine, 2011
- Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimatesThe Lancet, 2009
- Immunogenicity and serotype-specific efficacy of a 9-valent pneumococcal conjugate vaccine (PCV-9) determined during an efficacy trial in The GambiaVaccine, 2008
- Epidemiology and etiology of childhood pneumoniaBulletin of the World Health Organization, 2008
- Pneumococcal conjugate vaccine for childhood immunization--WHO position paper.2007
- A Trial of a 9-Valent Pneumococcal Conjugate Vaccine in Children with and Those without HIV InfectionNew England Journal of Medicine, 2003
- Prospective multicentre hospital surveillance of Streptococcus pneumoniae disease in India. Invasive Bacterial Infection Surveillance (IBIS) Group, International Clinical Epidemiology Network (INCLEN)1999